The use of fillers and botulinum toxin type A in combination with superficial glycolic acid (alpha-hydroxy acid) peels: optimizing injection therapy with the skin-smoothing properties of peels.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Rendon MI;Rendon MI; Effron C; Edison BL
  • Source:
    Cutis [Cutis] 2007 Jan; Vol. 79 (1 Suppl Combining), pp. 9-12.
  • Publication Type:
    Journal Article; Review
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 0006440 Publication Model: Print Cited Medium: Print ISSN: 0011-4162 (Print) Linking ISSN: 00114162 NLM ISO Abbreviation: Cutis Subsets: MEDLINE
    • Publication Information:
      Publication: Parsippany, NJ : Frontline Medical Communications
      Original Publication: New York : Cahners Pub Co.
    • Subject Terms:
      Chemexfoliation* ; Dermabrasion*; Botulinum Toxins, Type A/*therapeutic use ; Glycolates/*therapeutic use ; Keratolytic Agents/*therapeutic use; Combined Modality Therapy ; Humans ; Injections, Intradermal ; Neuromuscular Agents/therapeutic use ; Skin Aging/drug effects ; Skin Diseases/physiopathology ; Skin Diseases/therapy ; Treatment Outcome
    • Abstract:
      There are many procedures that a physician may utilize to improve the appearance and quality of the skin. Combining procedures can enhance the overall result and lead to increased patient satisfaction. Thus, it is important to choose procedures that will complement each other. Fillers or botulinum toxin type A (BTX-A) can plump the skin and smooth lines and wrinkles but will do little for uneven tone, skin laxity, or radiance and clarity. These signs of aging can be addressed with superficial glycolic acid peels. Methods of combining injectable compounds with superficial glycolic acid peels were discussed at a dermatologist roundtable event and are summarized in this article.
    • Number of References:
      13
    • Accession Number:
      0 (Glycolates)
      0 (Keratolytic Agents)
      0 (Neuromuscular Agents)
      0WT12SX38S (glycolic acid)
      EC 3.4.24.69 (Botulinum Toxins, Type A)
    • Publication Date:
      Date Created: 20070426 Date Completed: 20070808 Latest Revision: 20161124
    • Publication Date:
      20231215
    • Accession Number:
      17455888